Nvidia stock experienced significant volatility during Monday’s trading session, closing up 3.5% after fluctuating as much as 7.9% higher and 8.2% lower. The market reacted to news on tariffs, initially plummeting before recovering slightly, with the S&P 500 down 0.3% and the Nasdaq Composite up 0.1%. Despite uncertainties surrounding tariffs and global economic conditions, Nvidia’s outlook remains uncertain, with potential impacts on customer spending and continued high levels of stock volatility expected.
Full Article
Why NovoCure Stock Was Withering on Wednesday
Cancer-focused biotech NovoCure (NVCR -4.07%) saw its stock price target cut by Wedbush analyst David Nierengarten from $29 to $27, leading to a nearly 5% drop in stock value amidst bearish sentiment. Despite a 21% year-over-year revenue growth in Q4 2024, the company reported a net loss of $0.61 per share, worse than analysts expected. While investors are impatient for positive news, the company remains well-positioned in cancer treatment, suggesting it may be a discount...
Read more